These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23154304)

  • 1. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
    Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
    Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One pot synthesis and biological activity evaluation of novel Schiff bases derived from 2-hydrazinyl-1,3,4-thiadiazole.
    Haj Mohammad Ebrahim Tehrani K; Sardari S; Mashayekhi V; Esfahani Zadeh M; Azerang P; Kobarfard F
    Chem Pharm Bull (Tokyo); 2013; 61(2):160-6. PubMed ID: 23183543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity.
    Mirfazli SS; Kobarfard F; Firoozpour L; Asadipour A; Esfahanizadeh M; Tabib K; Shafiee A; Foroumadi A
    Daru; 2014 Sep; 22(1):65. PubMed ID: 25238875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
    da Silveira IA; Paulo LG; de Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
    J Pharm Pharmacol; 1993 Jul; 45(7):646-9. PubMed ID: 8105062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antiplatelet and antithrombotic activities of resveratrol derivatives with NO-donor properties.
    Dutra LA; Guanaes JFO; Johmann N; Lopes Pires ME; Chin CM; Marcondes S; Dos Santos JL
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2450-2453. PubMed ID: 28400236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
    Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
    ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
    Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
    Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Pharmacological Evaluation of Novel Piperlongumine derivatives as Potential Antiplatelet Aggregation Candidate.
    Wang Y; Wang J; Li J; Zhang Y; Huang W; Zuo J; Liu H; Xie D; Zhu P
    Chem Biol Drug Des; 2016 Jun; 87(6):833-40. PubMed ID: 26706668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual anticoagulant/antiplatelet persulfated small molecules.
    Correia-da-Silva M; Sousa E; Duarte B; Marques F; Cunha-Ribeiro LM; Pinto MM
    Eur J Med Chem; 2011 Jun; 46(6):2347-58. PubMed ID: 21450376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester.
    Lee GY; Chang TS; Lee KS; Khil LY; Kim D; Chung JH; Kim YC; Lee BH; Moon CH; Moon CK
    Thromb Res; 2005; 115(4):309-18. PubMed ID: 15668191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives.
    Cunha AC; Figueiredo JM; Tributino JL; Miranda AL; Castro HC; Zingali RB; Fraga CA; de Souza MC; Ferreira VF; Barreiro EJ
    Bioorg Med Chem; 2003 May; 11(9):2051-9. PubMed ID: 12670656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiplatelet activity of some 2,7-di(N-cycloamino)-3-phenyl-1,8-naphthyridine derivatives.
    Ferrarini PL; Badawneh M; Franconi F; Manera C; Miceli M; Mori C; Saccomanni G
    Farmaco; 2001 Apr; 56(4):311-8. PubMed ID: 11421260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
    Liu X; Chen X; Qiu K; Zhang Z
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-pyrone compounds. II: Synthesis and antiplatelet effects of tetraoxygenated xanthones.
    Lin CN; Liou SS; Ko FN; Teng CM
    J Pharm Sci; 1992 Nov; 81(11):1109-12. PubMed ID: 1447715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted pyrazolylhydrazones: a new class of platelet aggregation inhibitors.
    Silveira IA; Paulo LG; Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
    Braz J Med Biol Res; 1991; 24(9):947-51. PubMed ID: 1797291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activity.
    Bruno O; Brullo C; Ranise A; Schenone S; Bondavalli F; Barocelli E; Ballabeni V; Chiavarini M; Tognolini M; Impicciatore M
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1397-400. PubMed ID: 11378363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target.
    Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G
    Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiosemicarbazone and thiazolylhydrazones of 1-indanone: As a new class of nonacidic anti-inflammatory and antiplatelet aggregation agents.
    Nazim U; Ahmed M; Ali B; Khan KM; Ali M; Kobarfard F; Arshia -; Ayatollahi SA; Hassan A; Jabeen A; Faheem A
    Pak J Pharm Sci; 2019 Jan; 32(1):15-19. PubMed ID: 30772785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New indole and triazino[5,4-b]indol-4-one derivatives: synthesis and studies as inotropics and inhibitors of blood platelet aggregation.
    Monge A; Aldana I; Font M; Arraras JA; Santiago E; Lopez-Unzu MJ; Martínez-de Irujo JJ; Alberdi E; Fernández-Alvárez E
    Arch Pharm (Weinheim); 1992 Jul; 325(7):439-52. PubMed ID: 1417456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.